Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Technology
1.2.2. Application
1.2.3. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in U.S.
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.8. List of Secondary Sources
1.8.1. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Technology Outlook
2.2.2. Application Outlook
2.3. Competitive Insights
Chapter 3. U.S. 3D Bioprinting Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Technological advancement in 3D printing
3.2.1.2. Rising geriatric population & utilization of 3D bioprinting to manage health conditions
3.2.1.3. Growing R&D support from public & private bodies
3.2.2. Market restraint analysis
3.2.2.1. Operational challenges related to 3D bioprinting
3.2.2.2. High cost of 3D bioprinting
3.3. U.S. Pet Dental Heath Market Analysis Tools
3.3.1. Industry Analysis - Porter’s Five Forces
3.3.1.1. Threat of new entrant
3.3.1.2. Threat of substitutes
3.3.1.3. Bargaining power of buyers
3.3.1.4. Bargaining power of suppliers
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political & legal landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
Chapter 4. U.S. 3D Bioprinting Market: Technology Estimates & Trend Analysis
4.1. U.S. 3D Bioprinting Market: Technology Dashboard
4.2. U.S. 3D Bioprinting Market: Technology Movement Analysis
4.3. U.S. 3D Bioprinting Market Size & Forecasts and Trend Analyses, 2018 to 2030
4.4. Magnetic Levitation
4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Inkjet-based
4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Syringe-based
4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.7. Laser-based
4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.8. Others
4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. U.S. 3D Bioprinting Market: Application Estimates & Trend Analysis
5.1. U.S. 3D Bioprinting Market: Application Dashboard
5.2. U.S. 3D Bioprinting Market: Application Movement Analysis
5.3. U.S. 3D Bioprinting Market Size & Forecasts and Trend Analyses, 2018 to 2030
5.4. Medical
5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Tissue and Organ Generation
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.3. Medical Pills
5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.4. Prosthetics and Implants
5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.5. Others
5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Dental
5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Biosensors
5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Consumer/Personal Product Testing
5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.8. Bioinks
5.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.9. Food and Animal Product
5.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Company/Competition Categorization
6.3. Vendor Landscape
6.3.1. List of key distributors and channel partners
6.3.2. Key customers
6.3.3. Key company market share analysis, 2023
6.3.4. EnvisionTEC, Inc.
6.3.4.1. Company overview
6.3.4.2. Financial performance
6.3.4.3. Product benchmarking
6.3.4.4. Strategic initiatives
6.3.5. Organovo Holdings, Inc.
6.3.5.1. Company overview
6.3.5.2. Financial performance
6.3.5.3. Product benchmarking
6.3.5.4. Strategic initiatives
6.3.6. Inventia Life Science PTY LTD
6.3.6.1. Company overview
6.3.6.2. Financial performance
6.3.6.3. Product benchmarking
6.3.6.4. Strategic initiatives
6.3.7. Allevi, Inc. (3D Systems)
6.3.7.1. Company overview
6.3.7.2. Financial performance
6.3.7.3. Product benchmarking
6.3.7.4. Strategic initiatives
6.3.8. Cellink Global
6.3.8.1. Company overview
6.3.8.2. Financial performance
6.3.8.3. Product benchmarking
6.3.8.4. Strategic initiatives
6.3.9. Stratasys
6.3.9.1. Company overview
6.3.9.2. Financial performance
6.3.9.3. Product benchmarking
6.3.9.4. Strategic initiatives
6.3.10. Vivax Bio, LLC
6.3.10.1. Company overview
6.3.10.2. Financial performance
6.3.10.3. Product benchmarking
6.3.10.4. Strategic initiatives
List of Tables
Table 1 List of abbreviations
Table 2 U.S. 3D Bioprinting Market, by Technology, 2018 - 2030 (USD Million)
Table 3 U.S. 3D Bioprinting Market, by Application, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 U.S. 3D bioprinting market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 End-use and end-use segment snapshot
Fig. 10 Sales channel and age segment snapshot
Fig. 11 Competitive landscape snapshot
Fig. 12 Market dynamics
Fig. 13 Porter’s Five Forces analysis
Fig. 14 PESTLE analysis
Fig. 15 U.S. 3D bioprinting market: Technology outlook and key takeaways
Fig. 16 U.S. 3D bioprinting market: Technology movement analysis
Fig. 17 Magnetic levitation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 18 Inkjet-based market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 Syringe-based market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Laser-based market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 U.S. 3D bioprinting market: Application outlook and key takeaways
Fig. 23 U.S. 3D bioprinting market: Application movement analysis
Fig. 24 Medical market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Tissue and organ generation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Medical pills market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Prosthetics and implants market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Dental market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Biosensors market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Consumer/personal product testing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Bioinks market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Food and animal product market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Company market share analysis, 2023
Fig. 35 Strategic Framework